Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Bone Marrow Transplantation

  Free Subscription


Articles published in Biol Blood Marrow Transplant

Retrieve available abstracts of 77 articles:
HTML format



Single Articles


    March 2020
  1. PEREZ K, Shah VV, Schiller GJ
    Addressing the MMR Re-Vaccination Guidelines for Allogenic Bone Marrow Transplant Patients: A response to The American Society for Transplantation and Cellular Therapy 2019 Position Statement.
    Biol Blood Marrow Transplant. 2020 Mar 21. pii: S1083-8791(20)30154.
    PubMed    


    February 2020
  2. DUARTE FB, Moura ATG, Funke VAM, Colturato VAR, et al
    IMPACT OF TREATMENT PRIOR TO ALLOGENEIC TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME: RESULTS OF THE LATIN AMERICAN BONE MARROW TRANSPLANT REGISTRY.
    Biol Blood Marrow Transplant. 2020 Feb 26. pii: S1083-8791(20)30104.
    PubMed     Abstract available


  3. MARTINEZ C, Carpio C, Heras I, Rios-Herranz E, et al
    Potential survival benefit for patients receiving allogeneic hematopoietic stem cell transplantation after nivolumab therapy for relapse/refractory Hodgkin lymphoma: Real-life experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantat
    Biol Blood Marrow Transplant. 2020 Feb 14. pii: S1083-8791(20)30087.
    PubMed     Abstract available


    December 2019
  4. BESNARD C, Schmitt C, Galmiche-Rolland L, Debray D, et al
    Bone marrow transplantation in congenital erythropoietic porphyria: Sustained efficacy but unexpected liver dysfunction.
    Biol Blood Marrow Transplant. 2019 Dec 13. pii: S1083-8791(19)30867.
    PubMed     Abstract available


    November 2019
  5. NAEIJE L, Kariminia A, Abdossamadi S, Pour SA, et al
    Anti-Thymocyte Globulin Prophylaxis Induces a Decrease in Naive Th Cells to Inhibit the Onset of Chronic Graft-versus-Host Disease: Results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 Study.
    Biol Blood Marrow Transplant. 2019 Nov 19. pii: S1083-8791(19)30782.
    PubMed     Abstract available


  6. SHAW A, Passweg JR, De La Fuente J, Bajwa R, et al
    Relapse of aplastic anemia with majority donor chimerism (donor-type aplasia) occurring late after bone marrow transplantation.
    Biol Blood Marrow Transplant. 2019 Nov 13. pii: S1083-8791(19)30750.
    PubMed     Abstract available


    September 2019
  7. BHANDARI R, Orgel E, Rushing T, Malicse K, et al
    Improving the Timeliness of Chemotherapy Administration in the Bone Marrow Transplant Unit.
    Biol Blood Marrow Transplant. 2019 Sep 25. pii: S1083-8791(19)30637.
    PubMed     Abstract available


  8. DIMITROVA D, Gea-Banacloche J, Steinberg SM, Sadler JL, et al
    Prospective study of a novel, radiation-free, reduced-intensity bone marrow transplantation platform for primary immunodeficiency diseases.
    Biol Blood Marrow Transplant. 2019 Sep 4. pii: S1083-8791(19)30558.
    PubMed     Abstract available


    June 2019
  9. VASU S, Jaglowski S
    Have We Achieved a Goldilocks Grade of Graft-Versus-Host Disease?
    Biol Blood Marrow Transplant. 2019;25:e189-e190.
    PubMed    


    May 2019
  10. PRATA PH, Resche-Rigon M, Blaise D, Socie G, et al
    Outcomes of Salvage Haploidentical Transplant with Post-transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
    Biol Blood Marrow Transplant. 2019 May 23. pii: S1083-8791(19)30324.
    PubMed     Abstract available


  11. PULSIPHER MA, Logan BR, Kiefer DM, Chitphakdithai P, et al
    Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.
    Biol Blood Marrow Transplant. 2019;25:955-964.
    PubMed     Abstract available


    April 2019
  12. DAHLBERG A, Milano F
    Improved Survival after Cord Blood Transplantation: Single-Center Experience in Pediatric Patients Over a 2-Decade Period.
    Biol Blood Marrow Transplant. 2019;25:e117-e118.
    PubMed    


  13. HOLMQVIST AS, Chen Y, Wu J, Battles K, et al
    Late Mortality after Allogeneic Bone Marrow Transplantation in Childhood for Bone Marrow Failure Syndromes and Severe Aplastic Anemia.
    Biol Blood Marrow Transplant. 2019;25:749-755.
    PubMed     Abstract available


    March 2019
  14. HOLSTEIN SA, Ye JC, Howard A, Bhutani M, et al
    Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.
    Biol Blood Marrow Transplant. 2019;25:e89-e97.
    PubMed     Abstract available


  15. RAJ K, Eikema DJ, McLornan DP, Olavarria E, et al
    Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation.
    Biol Blood Marrow Transplant. 2019;25:522-528.
    PubMed     Abstract available


    February 2019
  16. INAMOTO Y, Valdes-Sanz N, Ogawa Y, Alves M, et al
    Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Work
    Biol Blood Marrow Transplant. 2019;25:e46-e54.
    PubMed     Abstract available


  17. WADHWA A, Chen Y, Holmqvist A, Wu J, et al
    Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2).
    Biol Blood Marrow Transplant. 2019;25:328-334.
    PubMed     Abstract available


  18. ALOUSI A, Wang T, Hemmer MT, Spellman SR, et al
    Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.
    Biol Blood Marrow Transplant. 2019;25:270-278.
    PubMed     Abstract available


  19. ANDOLINA JR, Burke MJ, Hijiya N, Chaudhury S, et al
    Practice Patterns of Physician Treatment for Pediatric Chronic Myelogenous Leukemia.
    Biol Blood Marrow Transplant. 2019;25:321-327.
    PubMed     Abstract available


  20. GHAVAMZADEH A, Kasaeian A, Rostami T, Kiumarsi A, et al
    Comparable Outcomes of Allogeneic Peripheral Blood versus Bone Marrow Hematopoietic Stem Cell Transplantation in Major Thalassemia: A Multivariate Long-Term Cohort Analysis.
    Biol Blood Marrow Transplant. 2019;25:307-312.
    PubMed     Abstract available


  21. JONES K, Bryant S, Luo J, Kiesler P, et al
    Recombinant Pregnancy-Specific Glycoprotein 1 Has a Protective Role in a Murine Model of Acute Graft-versus-Host Disease.
    Biol Blood Marrow Transplant. 2019;25:193-203.
    PubMed     Abstract available


    January 2019
  22. MEIER JA, Haque M, Fawaz M, Abdeen H, et al
    T Cell Repertoire Evolution After Allogeneic Bone Marrow Transplantation: An Organizational Perspective.
    Biol Blood Marrow Transplant. 2019 Jan 21. pii: S1083-8791(19)30072.
    PubMed     Abstract available


  23. GEORGES GE
    Consider Allogeneic Bone Marrow Transplantation for Older, Fit Patients with Aplastic Anemia.
    Biol Blood Marrow Transplant. 2019 Jan 11. pii: S1083-8791(19)30064.
    PubMed    


    December 2018
  24. MCCURDY SR, Kanakry CG, Tsai HL, Gojo I, et al
    Development of Grade II Acute Graft-Versus-Host Disease is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.
    Biol Blood Marrow Transplant. 2018 Dec 30. pii: S1083-8791(18)31700.
    PubMed     Abstract available


    November 2018
  25. DE LA FUENTE J, Dhedin N, Koyama T, Bernaudin F, et al
    Haploidentical bone marrow transplant with post-transplant cyclophosphamide plus thiotepa improves donor engraftment in patients with sickle cell anemia: results of an international learning collaborative.
    Biol Blood Marrow Transplant. 2018 Nov 27. pii: S1083-8791(18)30772.
    PubMed     Abstract available


    October 2018
  26. ATSUTA Y, Kato S, Morishima Y, Ohashi K, et al
    Comparison of HLA allele mismatch and antigen mismatch in unrelated bone marrow transplantation in patients with leukemia.
    Biol Blood Marrow Transplant. 2018 Oct 8. pii: S1083-8791(18)30611.
    PubMed     Abstract available


  27. PALMER J, Scherber R, Girardo M, Geyer H, et al
    Patient Perspectives Regarding Allogeneic Bone Marrow Transplant in Myelofibrosis.
    Biol Blood Marrow Transplant. 2018 Oct 3. pii: S1083-8791(18)30600.
    PubMed     Abstract available


    July 2018
  28. DEZERN AE, Jones RJ, Brodsky RA
    Eculizumab Bridging Before Bone Marrow Transplant for Marrow Failure Disorders is Safe and Does Not Limit Engraftment.
    Biol Blood Marrow Transplant. 2018 Jul 25. pii: S1083-8791(18)30421.
    PubMed     Abstract available


  29. T BO, H G, N BA, A L, et al
    "Filgrastim following HLA-identical allogeneic bone marrow transplantation: long-term outcomes of a randomized trial".
    Biol Blood Marrow Transplant. 2018 Jul 20. pii: S1083-8791(18)30413.
    PubMed     Abstract available


    June 2018
  30. BAI L, Best G, Xia W, Peters L, et al
    Expression of intracellular reactive oxygen species (ROS) in haematopoietic stem cells (HSCs) correlates with time to neutrophil and platelet engraftment in patients undergoing autologous bone marrow transplantation.
    Biol Blood Marrow Transplant. 2018 Jun 19. pii: S1083-8791(18)30326.
    PubMed     Abstract available


  31. KATSANIS E, Sapp LN, Varner N, Koza S, et al
    Haploidentical bone marrow transplantation with post-transplant cyclophosphamide/bendamustine in pediatric and young adult patients with hematologic malignancies.
    Biol Blood Marrow Transplant. 2018 Jun 13. pii: S1083-8791(18)30319.
    PubMed     Abstract available


  32. KANAKRY CG, Luznik L
    Teaching a Young Dog New Tricks: Modifications to the Post-Transplantation Cyclophosphamide Haploidentical Transplantation Platform.
    Biol Blood Marrow Transplant. 2018;24:1108-1110.
    PubMed    


  33. CHIUSOLO P, Bug G, Olivieri A, Brune M, et al
    A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study.
    Biol Blood Marrow Transplant. 2018;24:1243-1249.
    PubMed     Abstract available


  34. SHENOY S, Walters MC, Ngwube A, Soni S, et al
    Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.
    Biol Blood Marrow Transplant. 2018;24:1216-1222.
    PubMed     Abstract available


    April 2018
  35. DEVADASAN D, Sun CW, Westin ER, Wu LC, et al
    Bone Marrow Transplantation after Nonmyeloablative Treosulfan Conditioning Is Curative in a Murine Model of Sickle Cell Disease.
    Biol Blood Marrow Transplant. 2018 Apr 21. pii: S1083-8791(18)30192.
    PubMed     Abstract available


    March 2018
  36. KUSUDA M, Kimura SI, Misaki Y, Yoshimura K, et al
    Association between Activated Partial Thromboplastin Time and the Amount of Infused Heparin at Bone Marrow Transplantation.
    Biol Blood Marrow Transplant. 2018 Mar 5. pii: S1083-8791(18)30110.
    PubMed     Abstract available


  37. ANAND S, Sarantopoulos S
    Chronic Graft-versus-Host Disease: A Long Road Ahead.
    Biol Blood Marrow Transplant. 2018;24:423-424.
    PubMed    


  38. QAYED M, Wang T, Hemmer MT, Spellman S, et al
    Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.
    Biol Blood Marrow Transplant. 2018;24:521-528.
    PubMed     Abstract available


    February 2018
  39. ELMARIAH H, Kasamon YL, Zahurak M, Macfarlane KW, et al
    Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related Donors.
    Biol Blood Marrow Transplant. 2018 Feb 13. pii: S1083-8791(18)30083.
    PubMed     Abstract available


  40. BURGER DR, Parker Y, Guinta K, Lindner D, et al
    PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Ry(null) Mice.
    Biol Blood Marrow Transplant. 2018;24:260-266.
    PubMed     Abstract available


  41. FUREY A, Rastogi S, Prince R, Jin Z, et al
    Bone Marrow Harvest in Pediatric Sibling Donors: Role of Granulocyte Colony-Stimulating Factor Priming and CD34(+) Cell Dose.
    Biol Blood Marrow Transplant. 2018;24:324-329.
    PubMed     Abstract available


  42. MCCURDY SR, Kanakry CG, Tsai HL, Kasamon YL, et al
    Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide.
    Biol Blood Marrow Transplant. 2018;24:343-352.
    PubMed     Abstract available


    January 2018
  43. KASAMON YL, Fuchs EJ, Zahurak M, Rosner GL, et al
    Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation.
    Biol Blood Marrow Transplant. 2018 Jan 17. pii: S1083-8791(18)30026.
    PubMed     Abstract available


  44. OLSSON RF
    Self-Destructive Behavior among Full-Donor Blood and Marrow Grafts and the Association with Long-Term Graft Function.
    Biol Blood Marrow Transplant. 2018;24:1-2.
    PubMed    


  45. MIKULSKA M, Raiola AM, Galaverna F, Balletto E, et al
    Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.
    Biol Blood Marrow Transplant. 2018;24:109-118.
    PubMed     Abstract available


    November 2017
  46. CIRILLO M, Tan P, Sturm M, Cole C, et al
    Cellular Immunotherapy for Haematological Malignancies: Beyond Bone Marrow Transplant.
    Biol Blood Marrow Transplant. 2017 Nov 1. pii: S1083-8791(17)30804.
    PubMed     Abstract available


    October 2017
  47. RAIOLA AM, Risitano A, Sacchi N, Giannoni L, et al
    Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High Dose Cyclophosphamide.
    Biol Blood Marrow Transplant. 2017 Oct 9. pii: S1083-8791(17)30757.
    PubMed     Abstract available


    August 2017
  48. LLOSA NJ, Cooke KR, Chen A, Gamper C, et al
    Reduced Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.
    Biol Blood Marrow Transplant. 2017 Aug 11. pii: S1083-8791(17)30634.
    PubMed     Abstract available


  49. UGAI T, Kanda Y, Morishima Y, Matsuo K, et al
    Role of Genetic Polymorphism of ALDH2 in Hematopoietic Stem Cell Transplantation.
    Biol Blood Marrow Transplant. 2017;23:1374-1380.
    PubMed     Abstract available


    July 2017
  50. IMUS PH, Blackford AL, Bettinotti M, Iglehart B, et al
    Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplant.
    Biol Blood Marrow Transplant. 2017 Jul 25. pii: S1083-8791(17)30605.
    PubMed     Abstract available


    May 2017
  51. KUREKCI E, Kupesiz A, Anak S, Ozturk G, et al
    Hematopoietic Stem Cell Transplantation Using Preimplantation Genetic Diagnosis and Human Leukocyte Antigen Typing for Human Leukocyte Antigen-Matched Sibling Donor: A Turkish Multicenter Study.
    Biol Blood Marrow Transplant. 2017;23:790-794.
    PubMed     Abstract available


  52. LIU HD, Ahn KW, Hu ZH, Hamadani M, et al
    Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.
    Biol Blood Marrow Transplant. 2017;23:767-775.
    PubMed     Abstract available


  53. HASHMI SK, Bredeson C, Duarte RF, Farnia S, et al
    National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.
    Biol Blood Marrow Transplant. 2017;23:717-725.
    PubMed     Abstract available


    March 2017
  54. DEZERN AE, Zahurak M, Symons H, Cooke K, et al
    Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia.
    Biol Blood Marrow Transplant. 2017;23:498-504.
    PubMed     Abstract available


  55. GRAVES SS, Rezvani A, Sale G, Stone D, et al
    A Canine Model of Chronic Graft-versus-Host Disease.
    Biol Blood Marrow Transplant. 2017;23:420-427.
    PubMed     Abstract available


    February 2017
  56. MIYAMOTO T, Fukuda T, Nakashima M, Henzan T, et al
    Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program.
    Biol Blood Marrow Transplant. 2017 Feb 17. pii: S1083-8791(17)30281.
    PubMed     Abstract available


  57. AL-HOMSI AS, Goodyke A, McLane M, Abdel-Mageed S, et al
    Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either Agent Alone.
    Biol Blood Marrow Transplant. 2017;23:255-261.
    PubMed     Abstract available


  58. SANO H, Hilinski JA, Applegate K, Chiang KY, et al
    African American Race Is a Newly Identified Risk Factor for Postengraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation.
    Biol Blood Marrow Transplant. 2017;23:357-360.
    PubMed     Abstract available


  59. PATRIARCA F, Cigana C, Massimo D, Lazzarotto D, et al
    Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation.
    Biol Blood Marrow Transplant. 2017;23:333-339.
    PubMed     Abstract available


  60. MALARD F, Labopin M, Stuhler G, Bittenbring J, et al
    Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the Europea
    Biol Blood Marrow Transplant. 2017;23:278-284.
    PubMed     Abstract available


  61. LANGE S, Steder A, Killian D, Knuebel G, et al
    Engraftment Efficiency after Intra-Bone Marrow versus Intravenous Transplantation of Bone Marrow Cells in a Canine Nonmyeloablative Dog Leukocyte Antigen-Identical Transplantation Model.
    Biol Blood Marrow Transplant. 2017;23:247-254.
    PubMed     Abstract available


    January 2017
  62. CHEN YB, Efebera YA, Johnston L, Ball ED, et al
    Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells.
    Biol Blood Marrow Transplant. 2017 Jan 16. pii: S1083-8791(17)30194.
    PubMed     Abstract available


  63. MAJZNER RG, Mogri H, Varadhan R, Brown P, et al
    Post-Transplant Cyclophosphamide after Bone Marrow Transplantation is Not Associated with an Increased Risk of Donor Derived Malignancy.
    Biol Blood Marrow Transplant. 2017 Jan 3. pii: S1083-8791(17)30065.
    PubMed     Abstract available


    November 2016
  64. KLEIN OR, Buddenbaum J, Tucker N, Chen AR, et al
    Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies.
    Biol Blood Marrow Transplant. 2016 Nov 22. pii: S1083-8791(16)30516.
    PubMed     Abstract available


  65. YOKOYAMA H, Kanda J, Fuji S, Kim SW, et al
    Impact of HLA allele mismatch in unrelated bone marrow transplantation with reduced intensity conditioning regimen.
    Biol Blood Marrow Transplant. 2016 Nov 11. pii: S1083-8791(16)30487.
    PubMed     Abstract available


  66. BONFIM C, Ribeiro L, Nichele S, Loth G, et al
    Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia.
    Biol Blood Marrow Transplant. 2016 Nov 7. pii: S1083-8791(16)30484.
    PubMed     Abstract available


    October 2016
  67. PATTON WN, Nivison-Smith I, Bardy P, Dodds A, et al
    Graft Transit Time Has No Effect on Outcome of Unrelated Donor Haematopoietic Cell Transplants Performed in Australia and New Zealand: a Study From the Australasian Bone Marrow Transplant Recipient Registry.
    Biol Blood Marrow Transplant. 2016 Oct 4. pii: S1083-8791(16)30389.
    PubMed     Abstract available


    May 2016
  68. KUMAR R, Kimura F, Ahn KW, Hu ZH, et al
    Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.
    Biol Blood Marrow Transplant. 2016;22:932-40.
    PubMed     Abstract available


    April 2016
  69. LANGE S, Steder A, Glass A, Killian D, et al
    Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
    Biol Blood Marrow Transplant. 2016;22:637-43.
    PubMed     Abstract available


  70. KANDA J, Brazauskas R, Hu ZH, Kuwatsuka Y, et al
    Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations.
    Biol Blood Marrow Transplant. 2016;22:744-51.
    PubMed     Abstract available


  71. MERKEL EC, Mitchell SA, Lee SJ
    Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.
    Biol Blood Marrow Transplant. 2016;22:752-8.
    PubMed     Abstract available


  72. BUCK K, Wadsworth K, Setterholm M, Maiers M, et al
    High-Resolution Match Rate of 7/8 and 9/10 or Better for the Be The Match Unrelated Donor Registry.
    Biol Blood Marrow Transplant. 2016;22:759-63.
    PubMed     Abstract available


    March 2016
  73. REDDY P, Cutler C
    Selected Reviews from the 2016 BMT Tandem Meetings.
    Biol Blood Marrow Transplant. 2016;22.
    PubMed    


    February 2016
  74. TERAKURA S, Atsuta Y, Tsukada N, Kobayashi T, et al
    Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia.
    Biol Blood Marrow Transplant. 2016;22:330-8.
    PubMed     Abstract available


  75. YOUNG JA, Logan BR, Wu J, Wingard JR, et al
    Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
    Biol Blood Marrow Transplant. 2016;22:359-70.
    PubMed     Abstract available


  76. GUIEZE R, Damaj G, Pereira B, Robin M, et al
    Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies.
    Biol Blood Marrow Transplant. 2016;22:240-7.
    PubMed     Abstract available


    January 2016
  77. JACOBY E, Chen A, Loeb DM, Gamper CJ, et al
    Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.
    Biol Blood Marrow Transplant. 2016;22:112-8.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bone Marrow Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: